Bhatt A D, Sane S P, Vaidya A B, Bolar H V
Medical Dept. Hindustan Ciba-Geigy Ltd., Bombay.
J Assoc Physicians India. 1993 Sep;41(9):571-2.
Patterns of rheumatic diseases and antirheumatic drug usage in different regions of India were analysed. The data was collected from a post-marketing surveillance of diclofenac sodium (Voveran) in 11931 patients. The common conditions were-rheumatoid arthritis (RA) 28.1%, osteoarthrosis (OA) 24.8%, soft-tissue rheumatism 12.4%, cervical spondylosis 6%, ankylosing spondylitis (AS) 3.5%, gout 2%. East zone had a significantly lower proportion of osteoarthritis (20.9%). The age distribution and sex ratios of RA, OA and AS were in line with literature reports. The severity of illness was moderate in 62% and duration was more than 6 months in 50.2%. Data on NSAID usage showed a preponderance of combinations and ibuprofen. There were no significant differences in NSAID usage across diseases or regions.
对印度不同地区的风湿性疾病模式和抗风湿药物使用情况进行了分析。数据收集自11931例患者的双氯芬酸钠（扶他林）上市后监测。常见病症为——类风湿关节炎（RA）28.1%、骨关节炎（OA）24.8%、软组织风湿病12.4%、颈椎病6%、强直性脊柱炎（AS）3.5%、痛风2%。东部地区骨关节炎的比例显著较低（20.9%）。RA、OA和AS的年龄分布及性别比例与文献报道一致。62%的患者病情为中度，50.2%的患者病程超过6个月。非甾体抗炎药（NSAID）使用数据显示联合用药和布洛芬占主导。不同疾病或地区之间NSAID的使用情况无显著差异。
